The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors

被引：43

作者：

Strand, V

Hochberg, MC

机构：

[1] Stanford Univ, Palo Alto, CA 94304 USA

[2] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2002年 / 47卷 / 04期

关键词：

D O I：

10.1002/art.10560

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：349 / 355

页数：7

共 44 条

[1] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[2]

[Anonymous], 1988, BRIT MED J, V296, P320

[3]

Bacon PA, 2001, ARTHRITIS RHEUM, V44, P2707, DOI 10.1002/1529-0131(200112)44:12<2707::AID-ART456>3.0.CO

[4]

2-M

[5] Indobufen - An updated review of its use in the management of atherothrombosis [J].

Bhana, N ;

McClellan, KJ .

DRUGS & AGING, 2001, 18 (05) :369-388

[6] NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection [J].

Boers, M .

LANCET, 2001, 357 (9264) :1222-1223

[7] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[8] EVALUATION OF FLURBIPROFEN FOR PREVENTION OF REINFARCTION AND REOCCLUSION AFTER SUCCESSFUL THROMBOLYSIS OR ANGIOPLASTY IN ACUTE MYOCARDIAL-INFARCTION [J].

BROCHIER, ML .

EUROPEAN HEART JOURNAL, 1993, 14 (07) :951-957

[9] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. [J].

Catella-Lawson, F ;

Reilly, MP ;

Kapoor, SC ;

Cucchiara, AJ ;

DeMarco, S ;

Tournier, B ;

Vyas, SN ;

FitzGerald, GA .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) :1809-1817

[10] No reduction in cardiovascular risk with NSAIDs - including aspirin? [J].

Cleland, JGF .

LANCET, 2002, 359 (9301) :92-93

← 1 2 3 4 5 →